Addex Therapeutics (ADXN) Net Income (2018 - 2025)

Addex Therapeutics has disclosed Net Income across 8 years of filings, most recently posting -$4260.2 for Q4 2025.

• Net Income for Q4 2025 came in at -$4260.2, up 76.54% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.5 million (down 111.42% YoY), and the FY2025 annual result was $137911.1, down 98.99% from the prior year.
• Net Income came in at -$4260.2 for Q4 2025 at Addex Therapeutics, down from $142225.5 in the prior quarter.
• In the past five years, Net Income ranged from a high of $15.9 million in Q2 2024 to a low of -$9.1 million in Q4 2023.
• The 5-year median for Net Income is -$2.4 million (2023), against an average of -$1.7 million.
• Across the five-year window, Net Income tumbled 237.81% in 2023 and soared 761.78% in 2024, its largest moves.
• Addex Therapeutics' Net Income stood at -$4.8 million in 2021, then soared by 237.36% to $6.6 million in 2022, then sank by 237.81% to -$9.1 million in 2023, then surged by 99.8% to -$18155.9 in 2024, then jumped by 76.54% to -$4260.2 in 2025.
• The last three Net Income figures came in at -$4260.2 (Q4 2025), $142225.5 (Q2 2025), and -$1.6 million (Q1 2025), per Business Quant data.